WallStreetZenWallStreetZen

NASDAQ: PCSA
Processa Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PCSA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$11.1M
Current Profit Margin
0%

PCSA Return on Equity

Current Company
-141.4%
Current Industry
-63.5%
Current Market
188%
PCSA's Return on Equity (-141.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PCSA announces earnings.

PCSA Return on Assets

Current Company
-122.2%
Current Industry
2.9%
PCSA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PCSA Return on Capital Employed

Current Company
-219.96%
Current Industry
19.5%
PCSA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PCSA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PCSA$0.00-$11.04M-$11.12MN/AN/A
PTIX$0.00-$4.86M-$5.00MN/AN/A
IBIO$50.00k-$25.95M-$27.28M-43.46%N/A
MYMD$0.00-$4.00M-$8.22M-100.00%N/A
SCPX$6.99M-$36.93M-$45.22M+3.84%N/A
View Top Biotech Stocks

PCSA earnings dates

Next earnings date
Jun 27, 2024

Processa Pharmaceuticals Earnings & Revenue FAQ

What were PCSA's earnings last quarter?

On Invalid Date, Processa Pharmaceuticals (NASDAQ: PCSA) reported Q4 2023 earnings per share (EPS) of -$1.68, up 89.53% year over year. Total Processa Pharmaceuticals earnings for the quarter were -$2.40 million. In the same quarter last year, Processa Pharmaceuticals's earnings per share (EPS) was -$16.05.

If you're new to stock investing, here's how to buy Processa Pharmaceuticals stock.

What was PCSA's earnings growth in the past year?

As of Q2 2024, Processa Pharmaceuticals's earnings has grown year over year. Processa Pharmaceuticals's earnings in the past year totalled -$11.12 million.

What is PCSA's earnings date?

Processa Pharmaceuticals's earnings date is Invalid Date. Add PCSA to your watchlist to be reminded of PCSA's next earnings announcement.

What was PCSA's revenue last quarter?

On Invalid Date, Processa Pharmaceuticals (NASDAQ: PCSA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Processa Pharmaceuticals's revenue was $0.00.

What was PCSA's revenue growth in the past year?

As of Q2 2024, Processa Pharmaceuticals's revenue has grown null year over year. Processa Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.